THOP1 and central nervous system cancer: Approximately 10% of the total cellular content of THOP1 from AtT20 or glioma C6 cells were released to the extracellular milieu, where the enzyme could be metabolizing neuropeptides either into a soluble [19,111,112] or calcium-mediated membrane-bound form [113,114,115] (Figure 4).